GlobalData on MSN3d
MHLW accepts GSK’s multiple myeloma treatment NDA for reviewThe NDA includes a combination of Blenrep with bortezomib plus dexamethasone (BorDex) or pomalidomide plus dexamethasone ...
British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...
Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
InvestorsHub on MSN10d
GameStop plunges 11% on stock offering, DJT drops post-debate, GSK fails shingles vaccine trialGameStop announced an offering of up to 20 million shares. In Q2, GameStop reported revenue of $798.3 million, compared to $1 ...
4d
Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza ... and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback